openPR Logo
Press release

Chronic Lymphocytic Leukemia Therapeutics Market Research Report by Leading Key Players – GlaxoSmithKline, Roche, Teva Pharmaceuticals, Gilead Sciences, Novartis, Johnson & Johnson

01-24-2019 06:12 AM CET | Health & Medicine

Press release from: P&S Intelligence

Chronic Lymphocytic Leukemia Therapeutics Market Research

The global chronic lymphocytic leukemia therapeutics market is expected to create more opportunities in oncology due to promising pipeline and positive clinical data of drug candidates. The existing drugs for the treatment of chronic lymphocytic leukemia is the be most effective treatment. The American Cancer Society, and other regulatory bodies are supporting the chronic lymphocytic leukemia therapeutics market by providing funding and grants. The market is being driven by different factors such as rising awareness for the cancer treatments, high demand for safe and effective medications, technologies advancements, and increasing prevalence of cancer.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/chronic-lymphocytic-leukemia-therapeutics-market

Chronic lymphocytic leukemia is a type of gradually developing leukemia that affects the development of B lymphocytes (also known as B cells). On the other hand, B cells are specialized white blood cells, which produce immunoglobulins (also called antibodies) under normal conditions, and help to protect the human body against infections and diseases. In patients with chronic lymphocytic leukemia, lymphocytes undergo a malignant change and become leukemic cells.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/chronic-lymphocytic-leukemia-therapeutics-market/report-sample

Ono Pharmaceutical and Bristol-Myers Squibb are in the process of developing Opdivo for the treatment of chronic lymphocytic leukemia. Genentech is developing Atezolizumab, also known as MPDL 3280A, for chronic lymphocytic leukemia therapeutics, which is in Phase II stage. Atezolizumab is a monoclonal antibody targeting programmed cell death-1 ligand 1 (PD-L1). PD-L1 plays an important role in suppressing the immune system triggered by the cancer. PD-L1 acts by reducing the proliferation of antigen-specific CD8+ T-cells and controlling the accumulation of foreign antigen-specific T-cells.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=chronic-lymphocytic-leukemia-therapeutics-market

Many collaborations have been done by various pharmaceutical companies for the research and development of chronic lymphocytic leukemia treatment. The global chronic lymphocytic leukemia therapeutics market is driven by increased incidence and awareness of chronic lymphocytic leukemia. However, research and development expenditure, and side effects associated with the treatment, act as major restraints for the growth of the global chronic lymphocytic leukemia treatment market.

Some of the key players operating in the chronic lymphocytic leukemia therapeutics market are GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Celgene Corporation, Biogen Inc., AbbVie, Inc., Teva Pharmaceuticals Limited, Gilead Sciences, Inc., Novartis AG, and Johnson & Johnson.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Lymphocytic Leukemia Therapeutics Market Research Report by Leading Key Players – GlaxoSmithKline, Roche, Teva Pharmaceuticals, Gilead Sciences, Novartis, Johnson & Johnson here

News-ID: 1527759 • Views: 133

More Releases from P&S Intelligence

E-Signature Market Is Expected To Reach $12,721.5 Million by 2030
An electronic signature, often known as an e-signature, is a way to digitally sign contracts and other documents without using pen or paper. When carried out following e-signature legislation, electronic signatures have the same legal enforceability and validity as pen-and-paper documents, helping businesses save time and money. Why Is E-Signature Software Necessary for Businesses? In many firms, an average day is devoted to paperwork-contracts and other forms that must be completed, signed,
Slicing Software Market is predicted to Witness 16.7% CAGR during 2020-2030
The global slicing software market is predicted to reach a value of $2,202.5 million by 2030, rising from $422.2 million in 2019, progressing at a 16.7% CAGR during the forecast period (2020-2030), as per a report by P&S Intelligence. The primary factors leading to the growth of the market are the requirement for enhanced manufacturing speed, need for integrated slicing software, and increasing utilization of 3D printing in aerospace, healthcare,
Huge Revenue Explosion Expected in Global Certificate Authority Market From 2019 …
The global certificate authority market generated a revenue of $81.7 million in 2019 and is predicted to attain a value of $285.7 million in 2030, exhibiting a CAGR of 12.3% between 2020 and 2030. The key factors fueling the advancement of the market are the rising public awareness about protected and secure web access, increasing penetration of the internet, surging number of transactions that require authentication and a secure connection,
Global Webgame Market Set to Generate Over $6.0 Billion Revenue by 2030
The global webgame market generated a revenue of $3.5 billion in 2019 and is predicted to attain a valuation of $6.5 billion by 2030. According to the estimates of P&S Intelligence, a market research firm based in India, the market would progress at a CAGR of 5.7% between 2020 and 2030. The growing usage of tablets and smartphones and the increasing utilization of social media are the prominent two factors

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently